-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Pliant Therapeutics to Underweight

Benzinga·10/10/2025 11:36:28
Listen to the news
JP Morgan analyst Brian Cheng downgrades Pliant Therapeutics (NASDAQ:PLRX) from Neutral to Underweight.